Axion BioSystems
Manufacturing · Georgia, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1819 Peachtree Rd NE Ste 350, Atlanta, G...Phone Number
(404) 477-2557Website
www.axionbiosystems.comRevenue
$20.1 MillionIndustry
About Axion BioSystems
Axion BioSystems Org Chart
Is Axion BioSystems your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Axion BioSystems has new funding data
Check if Axion BioSystems has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Axion BioSystems is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Axion BioSystems
Earning: See what the market has to say on Axion BioSystems recently announced quarterly report
Click to see if Axion BioSystems had a recent Job posting/layoffs
Axion BioSystems, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Axion BioSystems launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Axion BioSystems
Compare insights from companies similar to Axion BioSystems, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Axion BioSystems is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Axion BioSystems is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Axion BioSystems.
Axion BioSystems financials insights
Gather financial insights about Axion BioSystems, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Private Equity
$6.3M
Debt
$350K
Debt
$963K
Axion BioSystems Tech Stack
A closer look at the technologies used by Axion BioSystems
Most Recent Scoops
Axion BioSystems News & Media
Axion BioSystems Continues Agreement Giving Corning® Exclusive Rights to Distribute Award-Winning Cell Counting Device
ATLANTA--(BUSINESS WIRE)-- #biotechnews--Axion BioSystems today announced an agreement with Corning Incorporated (NYSE: GLW) that continues Corning’s exclusive worldwide distribution rights for the Corning® Cell Counter. The simple yet powerful device, developed by Axion BioSystems and distributed by Corning, was recently included in the SelectScience® top 10 list of remarkable products advancing life science research. The agreement extends the successful collaboration between Corning and AxionAxion BioSystems Adds Affordable Maestro Volt™ to its Industry-Leading MEA System Lineup
ATLANTA--(BUSINESS WIRE)-- #biotech--Axion BioSystems today announced the launch of the new Maestro Volt™, an affordable benchtop microelectrode array (MEA) system designed to meet the demands of academic labs with lower throughput needs and limited budgets. Featuring the same ease of use, high-quality controls, and intuitive software synonymous with the Maestro name, the 6-well Maestro Volt is available for both neurological and cardiovascular research applications. The new device expands AxionAxion BioSystems Welcomes Biotech Industry Leader Julien Bradley as New CEO
ATLANTA--(BUSINESS WIRE)-- #Biotech--Axion BioSystems, a leading life science tools company focused on advanced live-cell assay platforms, today announced the appointment of Julien Bradley as the company’s new Chief Executive Officer. With nearly 20 years of experience in biotechnology development, commercialization, and leadership, Bradley will build on Axion’s growth in the fields of stem cell research, immuno-oncology, cell-based therapies, and drug discovery. Bradley has held executive and sFluorescent Imaging Market Growth Projected to Reach US$ 1,290.81 Million by 2030: Growth Plus Reports Study
Newark, New Castle - 19702, USA, April 10, 2023 (GLOBE NEWSWIRE) -- The global fluorescent imaging market is expected to reach US$ 1,290.81 million by 2030, with a revenue CAGR of 6.85%, according to a new Growth Plus Reports research. The research looks at key tactics, trends and potential, competition, evolving industry dynamics, market size, statistics and projections, and key investment territories.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Axion BioSystems
Founded in 2007, Axion BioSystems is a life science company developing technologies that solve problems related to human heart and brain activity. The company is based in Atlanta, GA.... Read More
